OLIMPIC: a 12-month study on the criteria driving retreatment with ranibizumab in patients with visual impairment due to myopic choroidal neovascularization
2019
Purpose To evaluate criteria driving retreatment with
ranibizumabin Italian patients with myopic
choroidal neovascularization(mCNV).
Keywords:
-
Correction
-
Source
-
Cite
-
Save
30
References
0
Citations
NaN
KQI